Catalyst Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,290
Closed -$173K 320
2022
Q3
$173K Hold
1,290
0.01% 198
2022
Q2
$198K Sell
1,290
-590
-31% -$90.2K 0.01% 220
2022
Q1
$305K Buy
1,880
+136
+8% +$19.8K 0.01% 208
2021
Q4
$236K Buy
1,744
+454
+35% +$53.6K 0.01% 216
2021
Q3
$139K Sell
1,290
-36,600
-97% -$4.18M 0.01% 248
2021
Q2
$4.27M Sell
37,890
-310
-0.8% -$34.9K 0.21% 73
2021
Q1
$4.13M Sell
38,200
-2,800
-7% -$299K 0.23% 74
2020
Q4
$4.39M Buy
+41,000
New +$3.94M 0.25% 64
2019
Q1
Sell
-1,900
Closed -$175K 391
2018
Q4
$175K Sell
1,900
-858
-31% -$75.5K 0.01% 231
2018
Q3
$261K Buy
2,758
+115
+4% +$10.9K 0.01% 229
2018
Q2
$245K Buy
2,643
+176
+7% +$17.2K 0.01% 225
2018
Q1
$234K Sell
2,467
-760
-24% -$83.5K 0.01% 240
2017
Q4
$312K Sell
3,227
-700
-18% -$66K 0.01% 231
2017
Q3
$349K Hold
3,927
0.02% 207
2017
Q2
$285K Sell
3,927
-308
-7% -$20.7K 0.01% 249
2017
Q1
$276K Sell
4,235
-52,755
-93% -$3.32M 0.01% 257
2016
Q4
$3.57M Sell
56,990
-11,041
-16% -$674K 0.23% 85
2016
Q3
$4.29M Buy
68,031
+54,001
+385% +$3.5M 0.47% 47
2016
Q2
$869K Hold
14,030
0.16% 148
2016
Q1
$801K Buy
14,030
+800
+6% +$44.6K 0.13% 129
2015
Q4
$784K Buy
13,230
+4,780
+57% +$275K 0.11% 136
2015
Q3
$460K Hold
8,450
0.06% 202
2015
Q2
$568K Sell
8,450
-5,000
-37% -$326K 0.07% 221
2015
Q1
$788K Sell
13,450
-80,068
-86% -$4.84M 0.09% 163
2014
Q4
$6.12M Buy
93,518
+9,529
+11% +$601K 0.72% 39
2014
Q3
$4.85M Buy
83,989
+790
+0.9% +$43.9K 0.63% 42
2014
Q2
$4.7M Buy
83,199
+11,326
+16% +$594K 0.77% 41
2014
Q1
$3.69M Buy
71,873
+13,118
+22% +$663K 0.84% 25
2013
Q4
$3.1M Buy
58,755
+24,970
+74% +$1.23M 1% 16
2013
Q3
$1.51M Buy
33,785
+25,335
+300% +$1.12M 0.83% 16
2013
Q2
$349K Buy
+8,450
New +$370K 0.27% 141

Other funds holding ABBV